AA Boudreault, H. Xie, RM Rakita, JD Scott, CL Davis, M. Boeckh, AP Limaye. Risk factors
for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney …

Background. During the contemporary era of antiviral prophylaxis, the impact of delayed-
onset primary cytomegalovirus (CMV) disease on the outcome of kidney transplantation is …

Background CMV-D+/R− serostatus is the only well-established risk factor for late-onset
cytomegalovirus (CMV) infection/disease (ie, incident CMV infection/disease after cessation …

Cytomegalovirus infection (CMV) in solid organ transplant recipients is a major clinical
problem. The aim of this study was to evaluate the incidence of CMV infection and its …

Background. Cytomegalovirus (CMV) D+/R− solid-organ transplant (SOT) recipients carry
increased risk of developing CMV disease; however, other risk factors in these patients have …

Background. Antiviral prophylaxis has been shown to decrease the incidence of
cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease …

Background Cytomegalovirus (CMV)‐negative recipients of a graft from a CMV‐positive
donor (D+/R−) are at high risk of CMV disease. Current preventive strategies include …

We assessed the impact of antiviral prophylaxis and preemptive therapy on the incidence
and outcomes of cytomegalovirus (CMV) disease in a nationwide prospective cohort of solid …

There is notable heterogeneity in the implementation of cytomegalovirus (CMV) prevention
practices among CMV‐seropositive (R+) kidney transplant (KT) recipients. In this …

Cytomegalovirus continues to be a concern after transplantation despite prophylaxis
regimens. Our aim was to analyse post‐prophylaxis primary cytomegalovirus infections …